Results 151 to 160 of about 24,637 (218)

Comparative Effectiveness of Sodium-Glucose Co-transporter 2 Inhibitors and Thiazolidinediones in Reducing Adverse Cardiovascular Events in Type 2 Diabetes. [PDF]

Cureus
Ali A, Sohail U, Rao T, Tariq F, Baig AM, Fatima SA.   +5 more
europepmc   +1 more source

Long-Term Glucagon-Like Peptide 1 Receptor Agonist Use Is Not Associated With Increased Risk of Thyroid Cancer in Adults With Type 2 Diabetes. [PDF]

Diabetes Metab Res Rev
Pollack R, Stokar J.
europepmc   +1 more source

Medications to reduce breast cancer risk: a network meta-analysis of randomized controlled trials. [PDF]

Breast Cancer Res
Pourali G, Liu M, Sherpa SS, Hardi A, Luo C, Toriola AT.   +5 more
europepmc   +1 more source

Effects of Brown Rice, Meal Replacements, and Anti-Obesity Drugs on Mitochondria in Obese Rats. [PDF]

Diabetes Metab Syndr Obes
Handayani D, Handayani A, Rudijanto A, Nuraissa P, Rahmawati W, Huang XF.   +5 more
europepmc   +1 more source

Case Report: Generalized lipodystrophy following immune-checkpoint inhibitor therapy. [PDF]

Front Endocrinol (Lausanne)
Lee AH, Hui R, Gunton JE.
europepmc   +1 more source

Evolving trends of antidiabetic agents stratified by age, kidney function and body mass index: Insights from a nationwide claims database. [PDF]

Diabetes Obes Metab
Aoyama K, Okada A, Kaneko H, Azegami T, Suzuki Y, Meguro S, Fujiu K, Takeda N, Morita H, Node K, Yamauchi T, Nangaku M, Takeda N, Yasunaga H, Hayashi K.   +14 more
europepmc   +1 more source

Peroxisome Proliferator-Activated Receptors (PPARs) in Psoriasis: Metabolic Intersections, Molecular Mechanisms, and Potential Treatments. [PDF]

Cureus
Pinnelli VBK, T SB, Ca J, Bhanu P, Murthuza AA, Thipani Madhu M, N S, Sam KT, Hussain MH, As A, Kandi V.   +10 more
europepmc   +1 more source

Implications of Genetic Elements on Type 2 Diabetes Mellitus Pathogenesis and Management. [PDF]

Endocrinol Diabetes Metab
Ngcobo NN, Sibiya NH.
europepmc   +1 more source

Caution in handling switchers in pharmacoepidemiologic studies estimating treatment effects: the example of dipeptidyl peptidase-4 inhibitors and inflammatory bowel disease. [PDF]

Am J Epidemiol
Wang T, Wang J, Song Z, Miller E, Pate V, Her Q, Yang J, Charlier SHR, Egger P, Barnes EL, Buse JB, Becker C, Sandler RS, Meier C, Jick S, Stürmer T.   +15 more
europepmc   +1 more source